Osphos is an injectable bisphosphonate solution for the control of clinical signs associated with navicular syndrome in horses 4 years and older. Osphos inhibits bone resorption by binding to calcium phosphate crystals (inhibiting their formation and dissolution), and by exerting direct cellular effects on osteoclasts.
